Nisa Investment Advisors’s Cidara Therapeutics CDTX Stock Holding History

Nisa Investment Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,384	Closed	-$968K	–	3053
2025 Q4	$968K	Sell	4,384 -2,364	-35%	-$382K	﹤0.01%	831
2025 Q3	$646K	Buy	6,748 +6,613	+4,899%	+$422K	﹤0.01%	959
2025 Q2	$6.58K	Buy	+135	New	+$3.24K	﹤0.01%	2397

Nisa Investment Advisors's CDTX Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 4,384 shares — an estimated $968K sold.

Nisa Investment Advisors first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $968K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Nisa Investment Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Nisa Investment Advisors sold 4,384 Cidara Therapeutics shares in Q1 2026, an estimated $968K.
Nisa Investment Advisors first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Nisa Investment Advisors's Cidara Therapeutics position peaked at $968K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.